Exposure to ethylene oxide in hospitals: Biological monitoring and influence of glutathione S-transferase and epoxide hydrolase polymorphisms

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 4, 2007, Pages 796-802

  Haufroid, Vincent ^a   Merz, Brigitte ^b   Hofmann, Annette ^b   Tschopp, Alois ^b   Lison, Dominique ^a   Hotz, Philippe ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYETHYLACETYLCYSTEINE; ACETYLCYSTEINE DERIVATIVE; BIOLOGICAL MARKER; EPOXIDE HYDROLASE; ETHYLENE OXIDE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG URINE LEVEL; ENZYME POLYMORPHISM; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINARY EXCRETION;

ADULT; AGED; BIOLOGICAL MARKERS; EPOXIDE HYDROLASES; ETHYLENE OXIDE; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HOSPITALS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34247537994     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0915     Document Type: Article

References (35)

1. Kolman A, Chovanec M, Ostermangolkar S. Genotoxic effects of ethylene oxide, propylene oxide, and epichlorohydrin in humans: update review (1990-2001). Mutat Res 2002;512:173-94.
2. Thier R, Bolt HF. Carcinogenicity and genotoxicity of ethylene oxide: new aspects and recent advances. Crit Rev Toxicol 2000;30:595-608.
3. Teta MJ, Sielken RL, Jr., Valdez-Flora C. Ethylene oxide cancer risk assessment based on epidemiological data: application of revised regulatory guidelines. Risk Anal 1999;19:1135-55.
4. IARC working group. Some industrial chemicals. Vol. 60. Lyon: IARC; 1994. p. 73-160.
5. Shore RE, Gardner MJ, Pannett B. Ethylene oxide - an assessment of the epidemiological evidence on carcinogenicity. Br J Ind Med 1993;50:971-97.
6. Romaguera C, Vilaplana J. Airborne occupational contact dermatitis from ethylene oxide. Contact Dermatitis 1997;39:85.
7. Ahlborg G, Hemminki K. Reproductive effects of chemical exposures in health professions. J Occup Environ Med 1995;37:957-61.
8. Fennell TR, Brown CD. A physiologically based pharmacokinetic model for ethylene oxide in mouse, rat, and human. Toxicol Appl Pharmacol 2001;173:161-75.
9. Filser JG, Kreuzer PE, Greim H, Bolt HM. New scientific arguments for regulation of ethylene oxide residues in skin-care products. Arch Toxicol 1994;68:401-5.
10. Brashear A, Unverzagt FW, Farber MO, Bonnin JM, Garcia JGN, Grober E. Ethylene oxide neurotoxicity: a cluster of 12 nurses with peripheral and central nervous system toxicity. Neurology 1996;46:992-8.
11. Wester RC, Hartway T, Serranzana S, Maibach HI. Human skin in vitro percutaneous absorption of gaseous ethylene oxide from fabric. Food Chem Toxicol 1997;35:513-5.
12. Haufroid V, Lison D. Mercapturic acids revisited as biomarkers of exposure to reactive chemicals in occupational toxicology: a minireview. Int Arch Occup Environ Health 2005;78:343-54.
13. Anonymous. Guide to occupational exposure values 2006. Cincinnati: ACGIH; 2006. p. 58.
14. Wolfs P, Dutrieux M, Scailteur V, Haxhe JJ, Zumofen M, Lauwerys R. Surveillance des travailleurs exposes a l'oxyde d'ethylene dans une entreprise de distribution de gaz sterilisants et dans des unites de sterilisation de materiel medical. Arch Mal Prof 1983;44:321-8.
15. Yong LC, Schulte PA, Wiencke JK, et al. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: effects of glutathione S-transferase T1 and M1 genotypes. Cancer Epidemiol Biomarkers Prev 2001;10:539-50.
16. Boogaard PJ. Use of haemoglobin adducts in exposure monitoring and risk assessment. J Chromatogr B Biomed Appl 2002;778:309-22.
17. Burgaz S, Rezanko R, Kara S, Karakaya AE. Thioethers in urine of sterilization personnel exposed to ethylene oxide. J Clin Pharm Ther 1992;17:169-72.
18. Popp W, Vahrenholz C, Przygoda H, et al. DNA-protein cross-links and sister chromatid exchange frequencies in lymphocytes and hydroxyethyl mercapturic acid in urine of ethylene oxide-exposed hospital workers. Int Arch Occup Environ Health 1994;66:325-32.
19. Calafat AM, Barr DB, Pirkle JL, Ashley DL. Reference range concentrations of N-acetyl-S-(hydroxyethyl)-L-cysteine, a common metabolite of several volatile organic compounds, in the urine of adults in the United States. J Expo Anal Environ Epidemiol 1999;9:336-42.
20. Landi S. Mammalian class θ GST and differential susceptibility to carcinogens: a review. Mutat Res 2000;463:247-83.
21. Strange RC, Jones PW, Fryer AA. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 2000;112:357-63.
22. LaMontagne AD, Mangione TW, Christiani DC, Kelsey KT. Medical surveillance for ethylene oxide exposure: practices and clinical findings in Massachusetts hospitals. J Occup Environ Med 1996;38:144-54.
23. LaMontagne AD, Kelsey KT. Evaluating OSHA's ethylene oxide standard: employer exposure-monitoring activities in Massachusetts hospitals from 1985 through 1993. Am J Public Health 1997;87:1119-25.
24. LaMontagne AD, Kelsey KT. OSHA's renewed mandate for regulatory flexibility review: in support of the 1984 ethylene oxide standard. Am J Ind Med 1998;34:95-104.
25. LaMontagne AD, Kelsey KT. Evaluating OSHA's ethylene oxide standard: exposure determinants in Massachusetts hospitals. Am J Public Health 2001;91:412-7.
26. Rollason JG, Pincherle G, Robinson D. Serum γ glutamyl transpeptidase in relation to alcohol consumption. Clin Chim Acta 1972;39:75-80.
27. NIOSH. Ethylene oxide. In: Schlecht PC, O'Connor PF, editors. NIOSH manual of analytical methods (NMAM). Cincinnati (OH): National Institute for Occupational Safety and Health; 1994. p. 1-6.
28. Barr DB, Ashley DL. A rapid, sensitive method for the quantitation of N-acetyl-S-(2-hydroxyethyl)-L-cysteine in human urine using isotope-dilution HPLC-MS-MS. J Anal Toxicol 1998;22:96-104.
29. Arand M, Muhlbauer R, Hengstler J, et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996;236:184-6.
30. Saarikoski ST, Voho A, Reinikainen M, et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 1998;77:516-21.
31. Haufroid V, Jakubowski M, Janasik B, et al. Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene. Pharmacogenetics 2002;12:691-702.
32. Vodicka P, Soucek P, Tates AD, et al. Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat Res 2001;482:89-103.
33. Richardson DB, Ciampi A. Effects to exposure measurement error when an exposure variable is constrained by a lower limit. Am J Epidemiol 2003;157:355-63.
34. Schisterman EF, Vexler A, Whitcomb BW, Liu A. The limitations due to exposure detection limits for regression models. Am J Epidemiol 2006;163:374-83.
35. Lauwerys RR, Hoet P. Industrial chemical exposure. Guidelines for biological monitoring. Boca Raton (FL): Lewis Publishers; 2001. p. 12-4, 520-33.